Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial-Reference-Cited by-同舟云学术

Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial

Published:2013-11-12 Issue:3 Volume:9 Page:273-277
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Penel Nicolas,Ray-Coquard Isabelle,Bal-Mahieu Christine,Chevreau Christine,Le Cesne Axel,Italiano Antoine,Bompas Emmanuelle,Clisant Stéphanie,Baldeyrou Brigitte,Lansiaux Amélie,Robin Yves-Marie,Bay Jacques-Olivier,Piperno-Neumann Sophie,Blay Jean-Yves,Fournier Charles

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11523-013-0299-0.pdf

Reference23 articles.

1. Penel N, Marreaud S, Robin YM, Hohenberger P (2011) Angiosarcoma: state of the art and perspectives. Crit Rev Oncol Hematol 80:257–263

2. Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, Kerbrat P, Fournier C, Taieb S, Jimenez M, Isambert N, Peyrade F, Chevreau C, Bompas E, Brain EG, Blay JY (2008) Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX study. J Clin Oncol 26:5269–5274

3. Mehrabi A, Kashfi A, Fonouni H, Schemmer P, Hallscheidt P, Schirmacher P, Weitz J, Friess H, Buchler MW, Schmidt J (2006) Primary malignant hepatic epithelioid hemangioendothelioma. Cancer 107:2108–2121

4. Kitaichi M, Nagai S, Nishimura K, Itoh H, Asamoto H, Izumi T, Dail DH (1998) Pulmonary epithelioid haemangioendothelioma in 21 patients, including three with partial spontaneous regression. Eur Respir J 12:89–96

5. Flaherty KT (2007) Sorafenib: delivering a targeted drug to the right targets. Expert Rev Anticancer Ther 7:617–626

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities;Cancers;2023-08-02

2. Molecular Profile of Canine Hemangiosarcoma and Potential Novel Therapeutic Targets;Veterinary Sciences;2023-06-05

3. Tumeurs rares : angiosarcome;Bulletin du Cancer;2023-05

4. Discovery and functional characterization of the oncogenicity and targetability of a novel NOTCH1-ROS1 gene fusion in pediatric angiosarcoma;CSH MOL CASE STUD;2022

5. Management of Cutaneous Angiosarcoma: an Update Review;Current Treatment Options in Oncology;2022-02